A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts
A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts
通過9名分析師的專業意見來了解輝瑞的前景
9 analysts have expressed a variety of opinions on Pfizer (NYSE:PFE) over the past quarter, offering a diverse set of opinions from bullish to bearish.
在過去的季度中，有9位分析師對輝瑞（紐交所:PFE）提出了各種不同的意見，從看漲到看淡不一。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $42.22, a high estimate of $45.00, and a low estimate of $29.00. This upward trend is apparent, with the current average reflecting a 3.33% increase from the previous average price target of $40.86.
分析師12個月的目標價顯示出平均目標價爲42.22美元，最高估價爲45.00美元，最低估價爲29.00美元。這種上漲趨勢是顯而易見的，當前的平均價格反映了對40.86美元的先前平均價格目標的3.33%的增長。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
A comprehensive examination...
從最近...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。